mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.14 |
0.001 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |